A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Clinical trial NCT06679946 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06679946
- Sponsor
- Alnylam Pharmaceuticals
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-03
- Primary completion
- 2028-03-31
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.